239 related articles for article (PubMed ID: 12470283)
21. New 4-point pharmacophore method for molecular similarity and diversity applications: overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures.
Mason JS; Morize I; Menard PR; Cheney DL; Hulme C; Labaudiniere RF
J Med Chem; 1999 Aug; 42(17):3251-64. PubMed ID: 10464012
[TBL] [Abstract][Full Text] [Related]
22. Efficient overlay of small organic molecules using 3D pharmacophores.
Wolber G; Dornhofer AA; Langer T
J Comput Aided Mol Des; 2006 Dec; 20(12):773-88. PubMed ID: 17051340
[TBL] [Abstract][Full Text] [Related]
23. Current insights into computer-aided immunotherapeutic design strategies.
Cai Z; Zhang G; Zhang X; Liu Y; Fu X
Int J Immunopathol Pharmacol; 2015 Sep; 28(3):278-85. PubMed ID: 26091813
[TBL] [Abstract][Full Text] [Related]
24. 3D-QSAR and receptor modeling of tyrosine kinase inhibitors with flexible atom receptor model (FLARM).
Peng T; Pei J; Zhou J
J Chem Inf Comput Sci; 2003; 43(1):298-303. PubMed ID: 12546565
[TBL] [Abstract][Full Text] [Related]
25. Structure and ligand-based design of P-glycoprotein inhibitors: a historical perspective.
Palmeira A; Sousa E; Vasconcelos MH; Pinto M; Fernandes MX
Curr Pharm Des; 2012; 18(27):4197-214. PubMed ID: 22827485
[TBL] [Abstract][Full Text] [Related]
26. Strategies for indirect computer-aided drug design.
Loew GH; Villar HO; Alkorta I
Pharm Res; 1993 Apr; 10(4):475-86. PubMed ID: 8483829
[TBL] [Abstract][Full Text] [Related]
27. Quantitative structure-activity relationship: promising advances in drug discovery platforms.
Wang T; Wu MB; Lin JP; Yang LR
Expert Opin Drug Discov; 2015 Dec; 10(12):1283-300. PubMed ID: 26358617
[TBL] [Abstract][Full Text] [Related]
28. Computer-Aided Drug Design: An Overview.
Talevi A
Methods Mol Biol; 2018; 1762():1-19. PubMed ID: 29594764
[TBL] [Abstract][Full Text] [Related]
29. Computer-aided drug design: the next 20 years.
Van Drie JH
J Comput Aided Mol Des; 2007; 21(10-11):591-601. PubMed ID: 17989929
[TBL] [Abstract][Full Text] [Related]
30. Pharmacophore modeling and three-dimensional database searching for drug design using catalyst.
Kurogi Y; Güner OF
Curr Med Chem; 2001 Jul; 8(9):1035-55. PubMed ID: 11472240
[TBL] [Abstract][Full Text] [Related]
31. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
[TBL] [Abstract][Full Text] [Related]
32. Pharmacophore filtering and 3D-QSAR in the discovery of new JAK2 inhibitors.
Dhanachandra Singh Kh; Karthikeyan M; Kirubakaran P; Nagamani S
J Mol Graph Model; 2011 Sep; 30():186-97. PubMed ID: 21831680
[TBL] [Abstract][Full Text] [Related]
33. Computer Aided Drug Design: Success and Limitations.
Baig MH; Ahmad K; Roy S; Ashraf JM; Adil M; Siddiqui MH; Khan S; Kamal MA; Provazník I; Choi I
Curr Pharm Des; 2016; 22(5):572-81. PubMed ID: 26601966
[TBL] [Abstract][Full Text] [Related]
34. Application of topological descriptors in QSAR and drug design: history and new trends.
Gozalbes R; Doucet JP; Derouin F
Curr Drug Targets Infect Disord; 2002 Mar; 2(1):93-102. PubMed ID: 12462157
[TBL] [Abstract][Full Text] [Related]
35. Editorial: The Concepts of Pharmacophore/Toxicophores: A Philosophical/Mathematical- cum-Historical Perspective.
Kier LB; Basak SC
Curr Comput Aided Drug Des; 2018; 14(2):103-105. PubMed ID: 29804527
[No Abstract] [Full Text] [Related]
36. The impact of pharmacophore modeling in drug design.
Guner OF
IDrugs; 2005 Jul; 8(7):567-72. PubMed ID: 15973565
[TBL] [Abstract][Full Text] [Related]
37. Epidermal growth factor receptor (EGFR) structure-based bioactive pharmacophore models for identifying next-generation inhibitors against clinically relevant EGFR mutations.
Panicker PS; Melge AR; Biswas L; Keechilat P; Mohan CG
Chem Biol Drug Des; 2017 Oct; 90(4):629-636. PubMed ID: 28303669
[TBL] [Abstract][Full Text] [Related]
38. Innovative computer-aided methods for the discovery of new kinase ligands.
Abuhammad A; Taha M
Future Med Chem; 2016 Apr; 8(5):509-26. PubMed ID: 27105126
[TBL] [Abstract][Full Text] [Related]
39. Novel strategies for the design of new potent and selective human A3 receptor antagonists: an update.
Moro S; Deflorian F; Bacilieri M; Spalluto G
Curr Med Chem; 2006; 13(6):639-45. PubMed ID: 16529556
[TBL] [Abstract][Full Text] [Related]
40. Small molecule crystallography in drug design.
Wouters J; Ooms F
Curr Pharm Des; 2001 May; 7(7):529-45. PubMed ID: 11375767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
